Members of the family &lt;i&gt;Lamiaceae&lt;/i&gt; Lindl. as sources of medicinal plant raw materials to obtain neurotropic drugs
Journal: Pharmacy & Pharmacology
Year: 2020

The aim of this work is to review and analyze the data published in the modern scientific literature obtained in pharmacological, pharmacognostic and pharmacotechnological studies of various types of raw materials obtained from members of the family Lamiaceae L., which were sources of biologically active substances, pharmaceutical substances, total extracts and the drugs – with a neurotropic activity. Materials and methods. For the review, we used the information of scientific literature from op